SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Morgan Stanley Reinstates Overweight on AbbVie, Announces $95 Price Target

Morgan Stanley reinstates AbbVie (NYSE:ABBV) with a Overweight and announces $95 price target.

Benzinga · 05/11/2020 12:37

Morgan Stanley reinstates AbbVie (NYSE:ABBV) with a Overweight and announces $95 price target.